CUSTOM STUDIES

I

II

III

IV-V

VI, etc.

Study type

First In Man

First In Man

Safety

Global Pivotal Trials

Post Market Registries

Sample size

30

100

90

2500-3000 (est.)

≥ 5000

Status

2 Yr Follow-Up Complete

1 Yr Follow-Up Complete

6 Month Follow-Up Complete

Planned

Planned